The Single-use Chromatography Systems for Medical industry trends have seen significant momentum over the past 18 months, driven by advancements in biologics manufacturing and a shift toward cost-efficient, scalable solutions. Key partnerships, such as Sartorius's collaboration with Merck KGaA to integrate AI-driven analytics into chromatography workflows, highlight efforts to enhance process optimization. Meanwhile, Cytiva (formerly GE Healthcare) launched its new ReadyToProcess single-use systems, tailored for high-capacity monoclonal antibody purification, reflecting growing demand for modular platforms. Regulatory updates by the FDA in late 2023 emphasizing risk mitigation in single-use systems have also prompted manufacturers to prioritize contamination prevention technologies. Notably, the acquisition of NuPharm Biotech by Danaher Corporation in 2024 underscores consolidation in the sector, aiming to strengthen downstream processing capabilities. Additionally, venture funding for startups like ChromaTek surged in early 2024, following a $50 million Series B round to scale their automated chromatography systems. As enterprises prioritize sustainability and end-to-end flexibility, the industry is poised for innovation in reusable hybrid systems and real-time data integration to meet evolving biopharma demands.